SCHEMBL25128239

SCHEMBL25128239

CC(=O)CCOCCOCCOCCOCCNC(=O)C(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.59
MEN1 O00255 1/20 0.59
CYP2C19 P33261 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
CA2 P00918 3/20 0.33
TLR2 O60603 2/20 0.33
HTT P42858 1/20 0.33
USP2 O75604 1/20 0.31
TSHR P16473 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPK1 P28482 1/20 0.31
GLP1R P43220 3/20 0.31
ALDH1A1 P00352 1/20 0.31
ECE1 P42892 1/20 0.31
NQO2 P16083 1/20 0.31
MTNR1A P48039 1/20 0.31
EPOR P19235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19050853 1.00 KMT2A (0.59) KMT2AMEN1CYP2C19CYP2D6CYP2C9
SCHEMBL18908735 0.89 KMT2A (0.73) KMT2AMEN1CYP2C19CYP2D6CYP2C9
SCHEMBL18908674 0.89 KMT2A (0.73) KMT2AMEN1CYP2C19CYP2D6CYP2C9
SCHEMBL10447931 0.89 KMT2A (0.73) KMT2AMEN1CYP2C19CYP2D6CYP2C9
SCHEMBL12387741 0.87 KMT2A (0.69) KMT2AMEN1CYP2C19CYP2D6CYP2C9
SCHEMBL26169621 0.86 KMT2A (0.51) KMT2AMEN1CYP2C19CYP2D6CYP2C9
SCHEMBL17175246 0.86 KMT2A (0.59) KMT2AMEN1CYP2C19CYP2D6CYP2C9
SCHEMBL27371560 0.86 KMT2A (0.59) KMT2AMEN1CYP2C19CYP2D6CYP2C9
SCHEMBL25128825 0.86 KMT2A (0.59) KMT2AMEN1CYP2C19CYP2D6CYP2C9
SCHEMBL25129535 0.86 KMT2A (0.59) KMT2AMEN1CYP2C19CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023040793-A1 ANTI-INFLAMMATORY COMPOUND AND USE THEREOF 映恩生物制药(苏州)有限公司 2023-03-23 WO disclosed